dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorGrassmann, Viviane
dc.creatorSantos-Galduróz, Ruth Ferreira
dc.creatorGalduróz, José Carlos Fernandes
dc.date2014-05-27T11:29:00Z
dc.date2016-10-25T18:47:51Z
dc.date2014-05-27T11:29:00Z
dc.date2016-10-25T18:47:51Z
dc.date2013-04-30
dc.date.accessioned2017-04-06T02:21:48Z
dc.date.available2017-04-06T02:21:48Z
dc.identifierCurrent Neuropharmacology, v. 11, n. 2, p. 186-196, 2013.
dc.identifier1570-159X
dc.identifier1875-6190
dc.identifierhttp://hdl.handle.net/11449/75193
dc.identifierhttp://acervodigital.unesp.br/handle/11449/75193
dc.identifier10.2174/1570159X11311020005
dc.identifierWOS:000317845300005
dc.identifier2-s2.0-84876706519
dc.identifierhttp://dx.doi.org/10.2174/1570159X11311020005
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/895940
dc.descriptionSince attention deficit/hyperactivity disorder (ADHD) presents high prevalence among children, science has been researching alternative forms of treatment that do not involve medication. Objective: To evaluate the effects of polyunsaturated fatty acids (PUFAs) on attention deficit/hyperactivity disorder. Methods: We reviewed the articles published between 1980 and 2012 indexed in the databases PubMed, APA psychNET, Scopus and Web of Knowledge. Results: Initially 231 articles were selected, out of which 12 met the inclusion criteria. The articles selected reported a modest cognitive and behavioral improvement of the patients after treatment with low doses of PUFAs. Those results might be associated with the evaluation methodology, the doses of PUFAs administered or the duration of treatment. © 2013 Bentham Science Publishers.
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.languageeng
dc.relationCurrent Neuropharmacology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAttention deficit/Hyperactivity disorder
dc.subjectBehavior
dc.subjectChildren
dc.subjectCognition
dc.subjectDietary supplements and polyunsaturated fatty acids
dc.subjectamphetamine
dc.subjectarachidonic acid
dc.subjectdexamphetamine
dc.subjectdocosahexaenoic acid
dc.subjectefalex
dc.subjectfish oil
dc.subjectgamma linolenic acid
dc.subjecticosapentaenoic acid
dc.subjectlinolenic acid
dc.subjectlinseed oil
dc.subjectmethylphenidate
dc.subjectmultivitamin
dc.subjectomega 3 fatty acid
dc.subjectomega 6 fatty acid
dc.subjectplacebo
dc.subjectpolyunsaturated fatty acid
dc.subjectprimrose oil
dc.subjectsunflower oil
dc.subjectunclassified drug
dc.subjectanxiety
dc.subjectattention deficit disorder
dc.subjectbehavior
dc.subjectcognition
dc.subjectcomorbidity
dc.subjectdrug megadose
dc.subjectDSM-IV
dc.subjecthuman
dc.subjecthyperactivity
dc.subjectimpulsiveness
dc.subjectnonhuman
dc.subjectrandomized controlled trial (topic)
dc.subjectreview
dc.subjectsystematic review
dc.titleEffects of low doses of polyunsaturated fatty acids on the attention deficit/Hyperactivity disorder of children: A systematic review
dc.typeOtro


Este ítem pertenece a la siguiente institución